These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 4625924

  • 1. Addiction and the community. (Narcotic substitution therapy).
    Taylor WJ, Chambers CD, Bowling CE.
    Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
    [No Abstract] [Full Text] [Related]

  • 2. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A.
    Adv Biochem Psychopharmacol; 1973 Apr; 8(0):399-414. PubMed ID: 4795072
    [No Abstract] [Full Text] [Related]

  • 3. Narcotic antagonists in the treatment of opiate dependence.
    Fink M, Zaks A, Resnick RB, Freedman AM.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
    [No Abstract] [Full Text] [Related]

  • 4. Advances in the treatment of drug addiction.
    Wilson CW.
    Practitioner; 1972 Oct; 209(252):536-43. PubMed ID: 4562348
    [No Abstract] [Full Text] [Related]

  • 5. 28. Methadone maintenance and its implication for theories of narcotic addiction.
    Dole VP, Nyswander ME.
    Res Publ Assoc Res Nerv Ment Dis; 1968 Oct; 46():359-66. PubMed ID: 5723803
    [No Abstract] [Full Text] [Related]

  • 6. XXVII. Opioid addiction problems in Canada.
    Holmes SJ.
    Res Publ Assoc Res Nerv Ment Dis; 1968 Oct; 46():347-58. PubMed ID: 5723802
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of opiate withdrawal syndromes (historical review)].
    Jeziorski K, Matsumoto H.
    Pol Tyg Lek; 1984 Oct 22; 39(43):1433-6. PubMed ID: 6151173
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological treatments for substance use disorders.
    Bailey KP.
    J Psychosoc Nurs Ment Health Serv; 2004 Aug 22; 42(8):14-20. PubMed ID: 15354595
    [No Abstract] [Full Text] [Related]

  • 11. The first methadone clinic in Beijing.
    Humeniuk R, Ali R.
    Drug Alcohol Rev; 2005 May 22; 24(3):285-7. PubMed ID: 16096132
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Narcotic antagonists. Treatment tool for addiction.
    Valentine NM, Meyer RE.
    Nurs Clin North Am; 1976 Sep 22; 11(3):541-9. PubMed ID: 785400
    [Abstract] [Full Text] [Related]

  • 14. What's happening in hard-drug rehabilitation?
    Walls RT, Gulkus SP.
    Rehabil Lit; 1973 Jan 22; 34(1):2-6. PubMed ID: 4683507
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC.
    Issue Brief Health Policy Track Serv; 2002 Dec 31; ():1-6. PubMed ID: 12875273
    [No Abstract] [Full Text] [Related]

  • 18. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG.
    J Pharmacol Exp Ther; 2003 Mar 31; 304(3):1033-41. PubMed ID: 12604679
    [Abstract] [Full Text] [Related]

  • 19. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV, Andreev BV.
    Eksp Klin Farmakol; 2000 Mar 31; 63(1):19-23. PubMed ID: 10763104
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.